On June 30, 2023, the Centers for Medicare & Medicaid Services ("CMS") issued its final guidance memorandum1 (the "Final Guidance") on the implementation of the Inflation Reduction Act ("IRA") Medicare Drug Price Negotiation Program for the Initial Price Applicability Year of 2026.